Compugen (CGEN) Accumulated Expenses (2020 - 2026)

Compugen recorded quarterly Accumulated Expenses of $4.0 million in Q1 2026, down 28.98% quarter-over-quarter from $5.7 million in Q4 2025.

Compugen's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $4.0 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses changed N/A year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (changed N/A YoY), while the FY2025 annual figure was $5.7 million, up 84.65% from the prior year.
  • Accumulated Expenses came in at $4.0 million for Q1 2026 at Compugen, down from $5.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $5.7 million in Q4 2025 to a low of $3.1 million in Q4 2024.
  • A 4-year average of $4.0 million and a median of $3.6 million in 2023 frame the typical range for Accumulated Expenses.
  • Across the five-year window, Accumulated Expenses retreated 1.63% in 2024 and jumped 84.65% in 2025, its largest moves.
  • Compugen's Accumulated Expenses stood at $3.1 million in 2023, then declined by 1.63% to $3.1 million in 2024, then soared by 84.65% to $5.7 million in 2025, then slipped by 28.98% to $4.0 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $4.0 million, $5.7 million, and $3.1 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.03 Mn
Dec 31, 2025 5.68 Mn
Jun 30, 2025 4.93 Mn
Dec 31, 2024 5.17 Mn
Jun 30, 2024 8.22 Mn
Dec 31, 2023 3.13 Mn
Dec 31, 2021 3.30 Mn
Dec 31, 2020 2.88 Mn